touchPODCAST

touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team evaluate the strategies for identifying and monitoring immune-related adverse events. The multidisciplinary team: Medical oncologist: Prof. Ken Kato, National Cancer Center Hospital, Tokyo, Japan Oncology nurse: Ms Tara Hurley, Royal Marsden NHS Foundation Trust, Sutton, UK Clinical oncology pharmacist: Dr Alison Palumb...

touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team review the role of biomarkers in informing immune checkpoint inhibitor use across tumour types. The multidisciplinary team Medical oncologist: Prof. Ken Kato, National Cancer Center Hospital, Tokyo, Japan Pathologist: Prof. Albrecht Stenzinger, University Hospital Heidelberg, Heidelberg, Germany This touchPODCAST is for...

touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team evaluate the strategies for identifying and monitoring immune-related adverse events. The multidisciplinary team: Medical oncologist: Prof. Ken Kato, National Cancer Center Hospital, Tokyo, Japan Oncology nurse: Ms Tara Hurley, Royal Marsden NHS Foundation Trust, Sutton, UK Clinical oncology pharmacist: Dr Alison Palumb...

touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team discuss the current and upcoming indications for immune checkpoint inhibitors in patients with solid tumours and review general considerations for their use. The multidisciplinary team: Medical oncologist: Prof. Ken Kato, National Cancer Center Hospital, Tokyo, Japan Oncology nurse: Ms Tara Hurley, Royal Marsden NHS Fou...

touchPANEL DISCUSSION for touchONCOLOGY Listen to an oncologist, urologist and nurse discuss adverse event identification and management with immunotherapies and targeted therapies for locally advanced or metastatic urothelial carcinoma.  The experts: Dr Axel Merseburger, University Hospital Schleswig-Holstein, Campus Lübeck, Germany Dr André Fay, PUCRS School of Medicine, Porto Alegre, Brazil Ms...

touchIN CONVERSATION for touchINFECTIOUS DISEASES Listen to Dr Farhan Fazal (Sheikh Khalifa Medical City Hospital, Abu Dhabi, UAE) in conversation with Dr Nada Melhem (American University of Beirut, Beirut, Lebanon). They respond to questions submitted by the HCP audience and provide their expert insights on COVID-19 vaccination challenges and strategies for improving vaccine uptake in the Middle...

touchEXPERT OPINIONS for touchENDOCRINOLOGY In this first of a two-part series, a medical physicist and a radiation oncologist provide a scientific and clinical primer on radiopharmaceuticals in adult oncology. The experts: Dr Stephen Graves, University of Iowa, Iowa City, IA, USA Dr Ana Kiess, Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, U...

touchEXPERT OPINIONS for touchONCOLOGY In this first of a two-part series, a medical physicist and a radiation oncologist provide a scientific and clinical primer on radiopharmaceuticals in adult oncology. The experts: Dr Stephen Graves, University of Iowa, Iowa City, IA, USA Dr Ana Kiess, Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA Th...

touchIN CONVERSATION for touchINFECTIOUS DISEASES Listen to Dr John Amuasi (Kwame Nkrumah University of Science and Technology, Kumasi, Ghana) in conversation with Dr Christina Obiero (Kenya Medical Research Institute, Kilifi, Kenya). They respond to questions submitted by the HCP audience and provide their expert insights on COVID-19 vaccination challenges and strategies for improving vaccine upt...

touchEXPERT OPINIONS for touchONCOLOGY Listen to three leading experts sharing their perspectives on the impact of the 2022 guideline updates on diagnosis, classification and management of higher-risk myelodysplastic neoplasms (MDS) and acute myeloid leukaemia (AML).  The experts: Prof. Andrew Wei, Peter MacCallum Cancer Centre, Walter and Eliza Hall Institute of Medical Research, Melbourne, Austr...

touchEXPERT OPINIONS for touchHAEMATOLOGY Listen to three leading experts sharing their perspectives on the impact of the 2022 guideline updates on diagnosis, classification and management of higher-risk myelodysplastic neoplasms (MDS) and acute myeloid leukaemia (AML).  The experts: Prof. Andrew Wei, Peter MacCallum Cancer Centre, Walter and Eliza Hall Institute of Medical Research, Melbourne, Au...

touchCONGRESS for touchONCOLOGY Listen to renowned experts in gynaecological oncology Dr Domenica Lorusso, Dr Susana Banerjee and Prof. Frederik Marmé review key data presented at SGO 2023 on recent developments in the use of PARP inhibitors in ovarian cancer. Aspects covered include first-line maintenance therapy, selection and sequencing implications, and future directions including emerging neo...

touchEXPERT OPINIONS for touchCARDIO Listen to three experts as they share their perspectives and best-practice guidance on how to optimize the diagnosis and management of pulmonary arterial hypertension. The experts: Prof. Harrison Farber, Tufts Medical Center, Boston, MA, USA Prof. Marion Delcroix, University Hospitals Leuven, Belgium Prof. Stephan Rosenkranz, University of Cologne, Germany This...

touchEXPERT OPINIONS for touchRESPIRATORY Listen to three experts as they share their perspectives and best-practice guidance on how to optimize the diagnosis and management of pulmonary arterial hypertension. The experts: Prof. Harrison Farber, Tufts Medical Center, Boston, MA, USA Prof. Marion Delcroix, University Hospitals Leuven, Belgium Prof. Stephan Rosenkranz, University of Cologne, Germany...

touchCONGRESS for touchONCOLOGY Listen to renowned renal cell carcinoma (RCC) expert Prof. Brian Rini review key data presented at the ASCO GU 2023 congress on advances in immune checkpoint inhibitor (ICI)-based regimens for RCC. He also discusses with two additional leading RCC experts, Prof. Elizabeth Plimack and Prof. Thomas Powles, how these data may apply in clinical practice. Overview: Data...

touchSATELLITE SYMPOSIUM for touchNEUROLOGY Listen to this touch satellite symposium recorded live in March 2023 at the AD/PD™ 2023 International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders. Prof. Jeffrey Cummings (University of Nevada, Las Vegas, NV, USA), the chair for the symposium, is joined by Prof. Liana Apostolova (Indiana University School of Medic...

touchPANEL DISCUSSION for touchINFECTIOUS DISEASES Listen to a panel of regional experts discuss the current landscape of COVID-19 vaccination, possible barriers to vaccine uptake and strategies involving healthcare workers that may help to improve acceptance of the COVID-19 vaccine, with a focus on Africa and the Middle East. The experts: Dr Angus Thomson, IRIMI company, Lyon, France Dr Amaya Gil...

touchEXPERT OPINIONS for touchONCOLOGY Listen to three experts provide their insights on unmet needs, emerging therapies, and the importance of biomarker testing in HER2-negative gastric cancer/gastroesophageal junction cancer. The experts: Dr Reetu Mukherji, MedStar Georgetown Lombardi Comprehensive Cancer Center, Washington DC, USA Dr Jaffer Ajani, Houston, TX, USA Dr Nataliya Uboha, University...

touchPANEL DISCUSSION for touchONCOLOGY Listen to a panel of leading experts discuss the role of biomarkers in optimizing the treatment of colorectal cancer, and how biomarkers are shaping the evolving treatment landscape.  The experts: Dr Kei Muro, Aichi Cancer Center Hospital, Nagoya, Japan Dr Chiara Cremolini, University of Pisa, Pisa, Italy Dr Rachel Riechelmann, AC Camargo Cancer Center, São...

touchPANEL DISCUSSION for touchONCOLOGY Listen to a panel of three oncology pharmacists discuss how to improve outcomes for patients experiencing immune-related adverse events after receiving immunotherapy for cancer treatment.  The experts;  Dr Sandra Cuellar, University of Illinois, Chicago, IL, USA;  Dr Sonia Amin Thomas, Wellstar North Fulton Hospital and Northwest Georgia Oncology Center, Ros...

touchMDT for touchENDOCRINOLOGY A pituitary surgeon, an endocrinologist and a patient with Cushing’s disease in remission discuss management challenges, including diagnostic delay and associated comorbidities, and the goals of medical therapy in Cushing’s disease. The multidisciplinary team Pituitary surgeon: Dr Timothy Smith, Boston, MA, USA, Endocrinologist: Dr Laurence Katznelson, Stanford, CA,...

touchMDT for touchENDOCRINOLOGY An endocrinologist, a pituitary surgeon and a pituitary nurse specialist review treatment pathways for patients with Cushing’s disease, with a focus on medical therapies, and provide insights on the efficacy and safety of approved medical agents. Pituitary surgeon: Dr Timothy Smith, Boston, MA, USA, Endocrinologist: Dr Laurence Katznelson, Stanford, CA, USA, Pituita...

touchMDT for touchENDOCRINOLOGY An endocrinologist, a pituitary surgeon, a pituitary nurse specialist and a patient with Cushing's disease in remission share their views on how the multidisciplinary team can support patients with Cushing’s disease. The multidisciplinary team Pituitary surgeon: Dr Timothy Smith, Boston, MA, USA Endocrinologist: Dr Laurence Katznelson, Stanford, CA, USA Pituitary nu...

touchPANEL DISCUSSION for touchONCOLOGY Listen to a panel of leading experts discuss the role of biomarkers in optimizing the treatment of colorectal cancer, and how biomarkers are shaping the evolving treatment landscape.  The experts Dr Kei Muro, Aichi Cancer Center Hospital, Nagoya, Japan Dr Chiara Cremolini, University of Pisa, Pisa, Italy Dr Rachel Riechelmann, AC Camargo Cancer Center, São P...

touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team review novel approaches to overcome resistance to standard-of-care immunotherapy for non-driver mutation metastatic NSCLC, including new immune checkpoint inhibitor combinations and emerging novel targets. The multidisciplinary team: Oncology Pharmacist: Prof. Lisa Holle, University of Connecticut School of Medicine, St...